May 02, 2012, 03.04 PM | Source: Moneycontrol.com
Orchid Chemicals and Pharmaceuticals has got US FDA okay for Naratriptan Tablet, reports CNBC-TV18.
It touched an intraday high of Rs 183.40 and an intraday low of Rs 178.90. At 15:00 hrs the share was quoting at Rs 181.80, up Rs 2.15, or 1.20%.
It was trading with volumes of 124,178 shares. In the previous trading session, the share closed up 1.21% or Rs 2.15 at Rs 179.65.
The company's trailing 12-month (TTM) EPS was at Rs 22.64 per share. (Dec, 2011). The stock's price-to-earnings (P/E) ratio was 8.03. The latest book value of the company is Rs 160.99 per share. At current value, the price-to-book value of the company was 1.13. The dividend yield of the company was 1.65%.
Orchid Pharma Ltd has informed BSE that a meeting
"Orchid received the establishment inspection repo
"Orchid received the Establishment inspection repo
Orchid Pharma Ltd has informed BSE that Orchid rec
Tata Motors continued it upward movement post yest
Polaris Financial Technology has got banking solut
Patel Engineering Company has bagged order worth R